Anita Dushyanth
Stock Analyst at Berenberg
(2.58)
# 2,144
Out of 5,146 analysts
4
Total ratings
75%
Success rate
15.74%
Average return
Main Sectors:
Stocks Rated by Anita Dushyanth
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| URGN UroGen Pharma | Initiates: Buy | $20 | $21.18 | -5.57% | 1 | Apr 27, 2022 | |
| SERA Sera Prognostics | Initiates: Buy | $13 | $2.30 | +465.22% | 1 | Apr 27, 2022 | |
| BTAI BioXcel Therapeutics | Initiates: Buy | $1,200 | $1.76 | +68,081.82% | 1 | Apr 9, 2021 | |
| PCRX Pacira BioSciences | Initiates: Buy | $93 | $22.67 | +310.32% | 1 | Apr 9, 2021 |
UroGen Pharma
Apr 27, 2022
Initiates: Buy
Price Target: $20
Current: $21.18
Upside: -5.57%
Sera Prognostics
Apr 27, 2022
Initiates: Buy
Price Target: $13
Current: $2.30
Upside: +465.22%
BioXcel Therapeutics
Apr 9, 2021
Initiates: Buy
Price Target: $1,200
Current: $1.76
Upside: +68,081.82%
Pacira BioSciences
Apr 9, 2021
Initiates: Buy
Price Target: $93
Current: $22.67
Upside: +310.32%